Astria Therapeutics
ATXS
ATXS
33 hedge funds and large institutions have $52.8M invested in Astria Therapeutics in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
35% less capital invested
Capital invested by funds: $81.4M → $52.8M (-$28.7M)
Holders
33
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$752K | |
| 2 | +$588K | |
| 3 | +$202K | |
| 4 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$196K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$76.5K |
Top Sellers
| 1 | -$357K | |
| 2 | -$217K | |
| 3 | -$205K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$93.7K |
| 5 |
D.E. Shaw & Co
New York
|
-$61.9K |